Published in J Urol on September 01, 2002
The MAPP research network: design, patient characterization and operations. BMC Urol (2014) 1.56
Prostate secretions from men with chronic pelvic pain syndrome inhibit proinflammatory mediators. J Urol (2010) 1.46
Inflammation and benign prostatic hyperplasia. Urol Clin North Am (2008) 1.44
Mechanisms in prostatitis/chronic pelvic pain syndrome. J Urol (2004) 1.31
Prostatitis, sexually transmitted diseases, and prostate cancer: the California Men's Health Study. PLoS One (2010) 1.16
Etiology of chronic prostatitis/chronic pelvic pain syndrome: psychoimmunoneurendocrine dysfunction (PINE syndrome) or just a really bad infection? World J Urol (2013) 0.93
Fluoroquinolone-macrolide combination therapy for chronic bacterial prostatitis: retrospective analysis of pathogen eradication rates, inflammatory findings and sexual dysfunction. Asian J Androl (2011) 0.91
Preliminary experience with a terpene mixture versus ibuprofen for treatment of category III chronic prostatitis/chronic pelvic pain syndrome. World J Urol (2006) 0.90
High frequency of chronic bacterial and non-inflammatory prostatitis in infertile patients with prostatitis syndrome plus irritable bowel syndrome. PLoS One (2011) 0.84
Category III chronic prostatitis/chronic pelvic pain syndrome: insights from the National Institutes of Health Chronic Prostatitis Collaborative Research Network studies. Curr Urol Rep (2008) 0.84
Nutraceuticals in Prostate Disease: The Urologist's Role. Rev Urol (2008) 0.83
Recommendations for the evaluation of patients with prostatitis. World J Urol (2003) 0.83
Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients. Exp Ther Med (2014) 0.82
Update on urologic pelvic pain syndromes: highlights from the 2010 international chronic pelvic pain symposium and workshop, august 29, 2010, kingston, ontario, Canada. Rev Urol (2011) 0.80
The role of cytokines in prostatitis. World J Urol (2003) 0.79
Clinical significance of national institutes of health classification in patients with chronic prostatitis/chronic pelvic pain syndrome. Korean J Urol (2014) 0.79
Pelvic tenderness is not limited to the prostate in chronic prostatitis/chronic pelvic pain syndrome (CPPS) type IIIA and IIIB: comparison of men with and without CP/CPPS. BMC Urol (2007) 0.79
Semen analysis in chronic bacterial prostatitis: diagnostic and therapeutic implications. Asian J Androl (2009) 0.78
Chronic prostatitis: approaches for best management. Korean J Urol (2012) 0.78
The 6-fluoro-8-methoxy quinolone gatifloxacin down-regulates interleukin-8 production in prostate cell line PC-3. Antimicrob Agents Chemother (2006) 0.78
[Chronic prostatitis. Chronic pelvic pain syndrome]. Schmerz (2004) 0.78
Acupuncture and Traditional Chinese Medicine for the management of a 35-year-old man with chronic prostatitis with chronic pelvic pain syndrome. J Chiropr Med (2013) 0.75
Structural and functional alterations in the colonic microbiome of the rat in a model of stress induced irritable bowel syndrome. Gut Microbes (2017) 0.75
Clinical characterization of the prostatitis patient in Italy: a prospective urology outpatient study. World J Urol (2004) 0.75
Prospective Study on Association of Prostatic Calcifications with Clinical Symptoms and Results of Treatment in Men with type III prostatitis. Sci Rep (2017) 0.75
A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41
Prevalence of chronic kidney disease in the United States. JAMA (2007) 38.98
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81
Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med (2008) 18.60
Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99
Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem (2007) 13.80
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med (2003) 11.25
Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med (2002) 10.52
Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int (2003) 9.11
Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48
Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med (2007) 7.90
The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol (2003) 7.79
Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA (2008) 7.50
FGF23 induces left ventricular hypertrophy. J Clin Invest (2011) 7.22
Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66
Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int (2008) 5.90
Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA (2011) 5.86
Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med (2009) 5.58
The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Intern Med (2005) 5.45
APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med (2013) 5.00
A randomized trial of urodynamic testing before stress-incontinence surgery. N Engl J Med (2012) 4.59
Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis (2002) 4.34
Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol (2009) 4.16
Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol (2002) 4.13
Role of surgeon volume in radical prostatectomy outcomes. J Clin Oncol (2003) 4.11
Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey. Arch Intern Med (2006) 4.09
Emphysematous cystitis: a review of 135 cases. BJU Int (2007) 4.08
Androgen deprivation therapy increases cardiovascular morbidity in men with prostate cancer. Cancer (2007) 3.92
Prediction of erectile function following treatment for prostate cancer. JAMA (2011) 3.92
Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer. Ann Intern Med (2013) 3.74
Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med (2008) 3.71
Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med (2009) 3.69
Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis (2008) 3.34
Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol (2003) 3.31
Demographic and clinical characteristics of men with chronic prostatitis: the national institutes of health chronic prostatitis cohort study. J Urol (2002) 3.14
The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med (2004) 2.94
Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. Urology (2002) 2.94
Clinical risk factors for primary graft failure following lung transplantation. Chest (2003) 2.92
Uric acid and long-term outcomes in CKD. Am J Kidney Dis (2009) 2.86
Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med (2004) 2.82
Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis. JAMA (2011) 2.80
The economic impact of chronic prostatitis. Arch Intern Med (2004) 2.74
Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med (2007) 2.71
The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial. Eur Urol (2007) 2.70
Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med (2008) 2.66
Spirituality influences health related quality of life in men with prostate cancer. Psychooncology (2006) 2.65
Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial. Circulation (2011) 2.62
Overtreatment of men with low-risk prostate cancer and significant comorbidity. Cancer (2010) 2.61
Granulomatous prostatitis linked to HLA-DRB1*1501. J Urol (2004) 2.46
Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. BMJ (2002) 2.46
Quality-of-care indicators for early-stage prostate cancer. J Clin Oncol (2003) 2.44
Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis (2012) 2.42
Geographic and socioeconomic variation in the treatment of prostate cancer. J Clin Oncol (2005) 2.41
Prospective randomized trial comparing shock wave lithotripsy and ureteroscopy for lower pole caliceal calculi 1 cm or less. J Urol (2008) 2.40
Contemporary management of the painful bladder: a systematic review. Eur Urol (2011) 2.39
Diffusion of surgical innovation among patients with kidney cancer. Cancer (2008) 2.38
Prostate cancer severity among low income, uninsured men. J Urol (2008) 2.38